Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Implementing a 'Lead [Apron]-Free' Cardiac Catheterization: Current Status.
Journal: Current cardiology reports
Published: July 11, 2024
JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression.
Journal: British journal of haematology
Published: April 12, 2019
Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells.
Journal: Leukemia research
Published: December 11, 2018
The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker.
Journal: Expert review of molecular diagnostics
Published: March 06, 2018
The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma.
Journal: Targeted oncology
Published: December 13, 2017
Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
Journal: Molecular cancer research : MCR
Published: August 30, 2016
Anti-angiogenic and anti-multiple myeloma effects of oprozomib (OPZ) alone and in combination with pomalidomide (Pom) and/or dexamethasone (Dex).
Journal: Leukemia research
Published: August 15, 2016
Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2015
Dynamic heterogeneity of DNA methylation and hydroxymethylation in embryonic stem cell populations captured by single-cell 3D high-content analysis.
Journal: Experimental cell research
Published: October 09, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026